This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001 Oct 13;323(7317):854-8.

doi: 10.1136/bmj.323.7317.854.

The case against aggressive treatment of type 2 diabetes: critique of the UK prospective diabetes study

R M Ewart¹

Affiliations

PMID: 11597972
PMCID: PMC1121393
DOI: 10.1136/bmj.323.7317.854

Review

The case against aggressive treatment of type 2 diabetes: critique of the UK prospective diabetes study

R M Ewart. BMJ. 2001.

. 2001 Oct 13;323(7317):854-8.

doi: 10.1136/bmj.323.7317.854.

Author

R M Ewart¹

Affiliation

¹ Department of Family and Community Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA. rewart@siumed.edu

PMID: 11597972
PMCID: PMC1121393
DOI: 10.1136/bmj.323.7317.854

No abstract available

PubMed Disclaimer

Similar articles

Recent advances in pharmacological treatment of type 2 diabetes mellitus.
Parulkar AA, Fonseca VA. Parulkar AA, et al. Compr Ther. 1999 Aug-Oct;25(8-10):418-26. doi: 10.1007/BF02944293. Compr Ther. 1999. PMID: 10520444 Review.
United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
[No authors listed] [No authors listed] Ann Intern Med. 1998 Feb 1;128(3):165-75. doi: 10.7326/0003-4819-128-3-199802010-00001. Ann Intern Med. 1998. PMID: 9454524 Clinical Trial.
The treatment of type 2 diabetes: good news from the UK.
Smith RB, Mann JI. Smith RB, et al. N Z Med J. 1999 May 14;112(1087):149-50. N Z Med J. 1999. PMID: 10378808 No abstract available.
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
Turner RC, Cull CA, Frighi V, Holman RR. Turner RC, et al. JAMA. 1999 Jun 2;281(21):2005-12. doi: 10.1001/jama.281.21.2005. JAMA. 1999. PMID: 10359389 Clinical Trial.
Clinical practice. Initial management of glycemia in type 2 diabetes mellitus.
Nathan DM. Nathan DM. N Engl J Med. 2002 Oct 24;347(17):1342-9. doi: 10.1056/NEJMcp021106. N Engl J Med. 2002. PMID: 12397193 Review. No abstract available.

See all similar articles

Cited by

Pioglitazone for type 2 diabetes mellitus.
Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Richter B, et al. Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006060. doi: 10.1002/14651858.CD006060.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054272 Free PMC article.
Efficacy of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin: a systematic review and meta-analysis.
McIntosh B, Yu C, Lal A, Chelak K, Cameron C, Singh SR, Dahl M. McIntosh B, et al. Open Med. 2010;4(2):e102-13. Epub 2010 May 18. Open Med. 2010. PMID: 21686299 Free PMC article.
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials.
Boussageon R, Supper I, Bejan-Angoulvant T, Kellou N, Cucherat M, Boissel JP, Kassai B, Moreau A, Gueyffier F, Cornu C. Boussageon R, et al. PLoS Med. 2012;9(4):e1001204. doi: 10.1371/journal.pmed.1001204. Epub 2012 Apr 10. PLoS Med. 2012. PMID: 22509138 Free PMC article.
Are concomitant treatments confounding factors in randomized controlled trials on intensive blood-glucose control in type 2 diabetes? a systematic review.
Boussageon R, Supper I, Erpeldinger S, Cucherat M, Bejan-Angoulvant T, Kassai B, Cornu C, Gueyffier F. Boussageon R, et al. BMC Med Res Methodol. 2013 Aug 30;13:107. doi: 10.1186/1471-2288-13-107. BMC Med Res Methodol. 2013. PMID: 24229055 Free PMC article.
Rosiglitazone for type 2 diabetes mellitus.
Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Richter B, et al. Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD006063. doi: 10.1002/14651858.CD006063.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636824 Free PMC article.

See all "Cited by" articles

References

1. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet. 1998;352:837–853. - PubMed
1. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet. 1988;352:854–865. . (Erratum appears in Lancet 1998;352:1558.) - PubMed
1. Holman RR, Turner RC. Diabetes: the quest for basal normoglycaemia. Lancet. 1977;i:469–474. - PubMed
1. UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year. Diabetologia. 1983;24:404–411. - PubMed
1. Turner RC, Mann JI, Peto R. UK prospective study of therapies of maturity-onset diabetes [letter] Diabetologia. 1984;27:419. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information